James Boyer
Gastroenterology · New Haven, CTNPI 1447233267
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $35,544 of the $47,892 with a category attached, or 74.2%. 8 manufacturers reported payments, led by GSK at 32.8% of the total. Reporting peaked in 2023 at $33,288 and has fallen 86.2% since, to $4,589 in 2025. Among gastroenterology clinicians in CT with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 30 payments — averaging $1596.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$16K
- Astrazeneca UK Limited$14K
- Ipsen Biopharmaceuticals, Inc$9K
- Ipsen Innovation$4K
- Amgen$3K
- Vertex$2K
- plus $1K from 2 others
Across 5 payments — averaging $120,812 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Gilead$600K
- Ipsen Bioscience Inc.$4K
What the payments were for
- Consulting fees$35,54474%
- Speaking & faculty fees$9,66520%
- Travel & lodging$2,2435%
- Food & beverage$4391%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 12 | $15,690 |
| Astrazeneca UK Limited | 6 | $14,218 |
| Ipsen Biopharmaceuticals, Inc | 3 | $8,540 |
| Ipsen Innovation | 1 | $3,735 |
| Amgen | 3 | $2,712 |
| Vertex | 3 | $1,517 |
| Sebela Pharmaceuticals Inc. | 1 | $1,400 |
| Cook Medical LLC | 1 | $81 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- UPLIZNA$2,712
How this compares
$47,892 in reported general payments places this provider in the 90th percentile of 326 gastroenterology providers in Connecticut.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ursodiol | 11 | $2,390 |
Paid to pharmacies, not to this prescriber.
Other gastroenterology in New Haven
- Pramod MistryNew Haven$126K
- Daniel ZanchettiNew Haven$94K
- Pichamol JirapinyoNew Haven$84K
- Jill GaidosNew Haven$69K
- Myron BrandNew Haven$60K
- Harry AslanianNew Haven$52K
- Thiruvengadam MunirajNew Haven$45K
- Badr Al BawardyNew Haven$42K
- Mae TigheNew Haven$39K
- Priya JamidarNew Haven$36K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.